Identification of an aptamer binding to human osteogenic-induced progenitor cells

Nucleic Acid Therapeutics

Volumn 23, Issue 1, 2013, Pages 44-61

  Ardjomandi, Nina ^a   Niederlaender, Jan ^a   Aicher, Wilhelm K ^a   Reinert, Siegmar ^a   Schweizer, Ernst ^a   Wendel, Hans Peter ^a   Alexander, Dorothea ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; COMPLEMENTARY DNA; DOUBLE STRANDED DNA; MESSENGER RNA; SINGLE STRANDED DNA;

ARTICLE; BONE DEVELOPMENT; BONE MARROW; CELL ADHESION; CELL PROLIFERATION; CHONDROGENESIS; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; HUMAN; HUMAN CELL; JAW; JAW PERIOSTEAL CELL; MESENCHYMAL STROMA CELL; PERIOSTEUM; PLACENTA; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STEM CELL; TISSUE ENGINEERING;

ADIPOGENESIS; ADULT STEM CELLS; APTAMERS, NUCLEOTIDE; BASE SEQUENCE; CALCIFICATION, PHYSIOLOGIC; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; CHONDROGENESIS; GENE EXPRESSION; HUMANS; JAW; KINETICS; MICROSCOPY, ELECTRON, SCANNING; MOLECULAR SEQUENCE DATA; NUCLEIC ACID CONFORMATION; OSTEOGENESIS; PERIOSTEUM; SELEX APTAMER TECHNIQUE; SEQUENCE HOMOLOGY, NUCLEIC ACID; TISSUE ENGINEERING;

EID: 84873689444     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2012.0349     Document Type: Article

References (46)

1. AGATA, H., ASAHINA, I., YAMAZAKI, Y., UCHIDA, M., SHINOHARA, Y., HONDA, M.J., KAGAMI, H., and UEDA, M. (2007). Effective bone engineering with periosteum-derived cells. J. Dent. Res. 86, 79-83
2. ALEXANDER, D., ARDJOMANDI, N., MUNZ, A., FRIEDRICH, B., and REINERT, S. (2011). ECM remodeling components regulated during jaw periosteal cell osteogenesis. Cell. Biol. Int. 35, 973-80
3. ALEXANDER, D., HOFFMANN, J., MUNZ, A., FRIEDRICH, B., GEIS-GERSTORFER, J., and REINERT S. (2008). Analysis of OPLA scaffolds for bone engineering constructs using human jaw periosteal cells. J. Mater. Sci. Mater. Med. 19, 965-974
4. ALEXANDER, D., SCHAFER, F., MUNZ, A., FRIEDRICH, B., KLEIN, C., HOFFMANN, J., BUHRING, H.J., and REINERT, S. (2009). LNGFR induction during osteogenesis of human jaw periosteum-derived cells. Cell Physiol. Biochem. 24, 283-290
5. ALEXANDER, D., SCHAFER, F., OLBRICH, M., FRIEDRICH, B., BUHRING, H.J., HOFFMANN, J., and REINERT, S. (2010). MSCA-1/TNAP selection of human jaw periosteal cells improves their mineralization capacity. Cell Physiol. Biochem. 26, 1073-1080
6. APTE, R.S., MODI, M., MASONSON, H., PATEL, M., WHITFIELD, L., and ADAMIS, A.P. (2007). Pegaptanib 1-year systemic safety results from a safety-pharmacokinetic trial in patients with neovascular age-related macular degeneration. Ophthalmology 114, 1702-1712
7. AUGELLO, A., KURTH, T.B., and DE BARI, C. (2010). Mesenchymal stem cells: A perspective from in vitro cultures to in vivo migration and niches. Eur. Cell Mater. 20, 121-133
8. BAGALKOT, V., FAROKHZAD, O.C., LANGER, R., and JON, S. (2006). An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew. Chem. Int., Ed 45, 8149-8152
9. BIEBACK, K., KERN, S., KOCAOMER, A., FERLIK, K., and BUGERT, P. (2008). Comparing mesenchymal stromal cells from different human tissues: Bone marrow, adipose tissue and umbilical cord blood. Biomed. Mater. Eng. 18, S71-S76
10. BLANK, M., and BLIND, M. (2005). Aptamers as tools for target validation. Curr. Opin. Chem. Biol. 9, 336-342
11. BUHRING, H.J., BATTULA, V.L., TREML, S., BAREISS, P.M., GIESEKE, F., ROELOFS, H., DE ZWART, P., MULLER, I., SCHEWE, B., SKUTELLA, T. et al. (2009a). Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica 94, 173-184
12. BUHRING, H.J., TREML, S., CERABONA, F., DE ZWART, P., KANZ, L., and SOBIESIAK, M. (2009b). Phenotypic characterization of distinct human bone marrow-derived MSC subsets. Ann. N. Y. Acad. Sci. 1176, 124-134
13. BUNKA, D.H., and STOCKLEY, P.G. (2006). Aptamers come of age: At last. Nat. Rev. Microbiol. 4, 588-596
14. CERCHIA, L., DUCONGE, F., PESTOURIE, C., BOULAY, J., AISSOUNI, Y., GOMBERT, K., TAVITIAN, B., DE FRANCISCIS, V., and LIBRI D. (2005). Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase. PLoS Biol. 3, e123
15. CHAN, J., KENNEA, N.L., and FISK, N.M. (2007). Placental mesenchymal stem cells. Am. J. Obstet. Gynecol. 196, e18; author reply e18-19
16. CHAPMAN, J.A., and BECKEY, C. (2006). Pegaptanib: A novel approach to ocular neovascularization. Ann. Pharmacother. 40, 1322-1326
17. CHEN, H.W., MEDLEY, C.D., SEFAH, K., SHANGGUAN, D., TANG Z., MENG, L., SMITH, J.E., and TAN, W. (2008). Molecular recognition of small-cell lung cancer cells using aptamers. ChemMedChem 3, 991-1001
18. DE BARI, C., DELL'ACCIO, F., and LUYTEN, F.P. (2001). Human periosteum-derived cells maintain phenotypic stability and chondrogenic potential throughout expansion regardless of donor age. Arthritis Rheum. 44, 85-95
19. DE BARI, C., DELL'ACCIO, F., VANLAUWE, J., EYCKMANS, J., KHAN, I.M., ARCHER, C.W., JONES, E.A., MCGONAGLE, D., MITSIADIS, T.A., PITZALIS, C., et al. (2006). Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum. 54, 1209-1221
20. DEMARCO, F.F., CONDE, M.C., CAVALCANTI, B.N., CASAGRANDE, L., SAKAI, V.T., and NOR, J.E. (2011). Dental pulp tissue engineering. Braz. Dent. J. 22, 3-13
21. DHAR, S., GU, F.X., LANGER, R., FAROKHZAD, O.C., and LIPPARD, S.J. (2008). Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGAPEG nanoparticles. Proc. Natl. Acad. Sci. U. S. A. 105, 17356- 17361
22. DOMINICI, M., LE BLANC, K., MUELLER, I., SLAPERCORTENBACH, I., MARINI, F., KRAUSE, D., DEANS, R., KEATING, A., PROCKOP, D., and HORWITZ, E. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8, 315-317
23. ELLINGTON, A.D., and SZOSTAK, J.W. (1990). In vitro selection of RNA molecules that bind specific ligands. Nature 346, 818-822
24. ESPOSITO, C.L., CATUOGNO, S., DE FRANCISCIS, V., and CERCHIA, L. (2011). New insight into clinical development of nucleic acid aptamers. Discov. Med. 11, 487-496
25. FAMULOK, M., and MAYER, G. (2011). Aptamer Modules as Sensors and Detectors. Acc. Chem. Res. 44, 1349-1358
26. GUO, K., WENDEL, H.P., SCHEIDELER, L., ZIEMER, G., and SCHEULE, A.M. (2005). Aptamer-based capture molecules as a novel coating strategy to promote cell adhesion. J. Cell. Mol. Med. 9, 731-736
27. GUO, K.T., SCHAFER, R., PAUL, A., GERBER, A., ZIEMER, G., and WENDEL, H.P. (2006). A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells 24, 2220-2231
28. GUO, K.T., SCHAFER, R., PAUL, A., ZIEMER, G., and WENDEL, H.P. (2007a). Aptamer-based strategies for stem cell research. Mini Rev. Med. Chem. 7, 701-705
29. GUO, K.T., SCHARNWEBER, D., SCHWENZER, B., ZIEMER, G., and WENDEL, H.P. (2007b). The effect of electrochemical functionalization of Ti-alloy surfaces by aptamerbased capture molecules on cell adhesion. Biomaterials 28, 468-474
30. HE, X., MA, J., and JABBARI, E. (2008). Effect of grafting RGD and BMP-2 protein-derived peptides to a hydrogel substrate on osteogenic differentiation of marrow stromal cells. Langmuir 24, 12508-12516
31. HERSEL, U., DAHMEN, C., and KESSLER, H. (2003). RGD modified polymers: Biomaterials for stimulated cell adhesion and beyond. Biomaterials 24, 4385-4415
32. HOFFMANN, J., PAUL, A., HARWARDT, M., GROLL, J., REESWINKEL, T., KLEE, D., MOELLER, M., FISCHER, H., WALKER, T., GREINER, T. et al. (2008). Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J. Biomed. Mater. Res. A 84A, 614-621
33. HUTMACHER, D.W., and SITTINGER, M. (2003). Periosteal cells in bone tissue engineering. Tissue Eng. 9 Suppl 1, S45-S64
34. MAYER, G. (2009). The chemical biology of aptamers. Angew. Chem., Int. Ed. 48, 2672-2689
35. MAYER, G., AHMED, M.S., DOLF, A., ENDL, E., KNOLLE, P.A., and FAMULOK, M. (2010). Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures. Nat. Protoc. 5, 1993-2004
36. MEIRELLES, LDA S., and NARDI, N.B. (2009). Methodology, biology, and clinical applications of mesenchymal stem cells. Front. Biosci. 14, 4281-4298
37. PILZ, G.A., ULRICH, C., RUH, M., ABELE, H., SCHAFER, R., KLUBA, T., BUHRING, H.J., ROLAUFFS, B., and AICHER, W.K. (2011). Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells. Stem Cells Dev. 20, 635-646
38. RINGE, J., LEINHASE, I., STICH, S., LOCH, A., NEUMANN, K., HAISCH, A., HAUPL, T., MANZ, R., KAPS, C., and SITTINGER, M. (2008). Human mastoid periosteum-derived stem cells: Promising candidates for skeletal tissue engineering. J. Tissue Eng. Regen. Med. 2, 136-146
39. ROCHET, N., LEROY, P., FAR, D.F., OLLIER, L., LOUBAT, A., and ROSSI, B. (2003). CAL72: A human osteosarcoma cell line with unique effects on hematopoietic cells. Eur. J. Haematol. 70, 43-52
40. SCHOFER, M.D., FUCHS-WINKELMANN, S., GRABEDUNKEL, C., WACK, C., DERSCH, R., RUDISILE, M., WENDORFF, J.H., GREINER, A., PALETTA, J.R., and BOUDRIOT, U. (2008). Influence of poly(L-lactic acid) nanofibers and BMP-2-containing poly(L-lactic acid) nanofibers on growth and osteogenic differentiation of human mesenchymal stem cells. ScientificWorldJournal 8, 1269- 1279
41. TUERK, C., and GOLD, L. (1990). Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249, 505-510
42. VAVVAS, D., and D'AMICO, D.J. (2006). Pegaptanib (Macugen): Treating neovascular age-related macular degeneration and current role in clinical practice. Ophthalmol. Clin. North Am. 19, 353-360
43. WENDEL, H.P., AVCI-ADALI, M., PAUL, A., WILHELM, N., and ZIEMER, G. (2010). Upgrading SELEX technology by using lambda exonuclease digestion for single-stranded DNA generation. Molecules 15, 1-11
44. ZHOU, J., and ROSSI, J.J. (2011). Cell-specific aptamer-mediated targeted drug delivery. Oligonucleotides 21, 1-10
45. ZHU, S.J., CHOI, B.H., HUH, J.Y., JUNG, J.H., KIM, B.Y., and LEE, S.H. (2006). A comparative qualitative histological analysis of tissue-engineered bone using bone marrow mesenchymal stem cells, alveolar bone cells, and periosteal cells. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 101, 164-169
46. ZUK, P.A., ZHU, M., MIZUNO, H., HUANG, J., FUTRELL, J.W., KATZ, A.J., BENHAIM, P., LORENZ, H.P., and HEDRICK, M.H. (2001). Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng. 7, 211-228